XML 95 R48.htm IDEA: XBRL DOCUMENT v3.22.0.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 12 Months Ended
Jan. 28, 2021
Sep. 08, 2020
Jan. 26, 2021
Dec. 31, 2017
Dec. 31, 2021
Dec. 31, 2020
Sep. 30, 2021
May 24, 2021
Mar. 04, 2021
Sep. 25, 2020
Related Party Transactions (Details) [Line Items]                    
Percentage of issued and outstanding shares   20.00%                
Combination price per share (in Dollars per share)             $ 12      
Administrative and support services     $ 10,000              
Service fee         $ 110,000          
Aggregate principal amount   $ 300,000                
Outstanding amount $ 130,410                  
Reduce amount of promissory note                 $ 155,410  
Promissory balance amount                 $ 0  
Outstanding promissory note         0          
Working capital loans         $ 1,500,000          
Sale of price per share (in Dollars per share)         $ 1          
Advance Rent         $ 870          
Blade Therapeutics, Inc. [Member]                    
Related Party Transactions (Details) [Line Items]                    
Founder shares are no longer subject to forfeiture (in Shares)               4,200,000   5,000,000
Aggregate principal amount         12,200,000 $ 13,400,000        
Service charged         166,000 55,000        
Amounts payable related party         5,000          
Related party transaction description       the Company entered into a consulting agreement with a firm to provide investor relations services through a consultant related to a member of the Company’s board of directors. The amounts incurred for the services were $0.1 million for the year ended December 31, 2020. These amounts are reflected as general and administrative expenses in the accompanying consolidated statement of operations and comprehensive loss. In August 2020, the Company provided 60-day termination notice to the investor relation firm and had no transactions with this related party following the termination date. There were no amounts payable to this related party as of December 31, 2020.            
Cost incurred           300,000        
Amounts payable           100,000        
Convertible notes issued         4,000,000          
Convertible Notes [Member] | Blade Therapeutics, Inc. [Member]                    
Related Party Transactions (Details) [Line Items]                    
Convertible notes issued         $ 1,400,000 $ 400,000        
Founders [Member]                    
Related Party Transactions (Details) [Line Items]                    
Shares subject to forfeiture (in Shares)   750,000                
Over-Allotment Option [Member]                    
Related Party Transactions (Details) [Line Items]                    
Founder shares are no longer subject to forfeiture (in Shares)   750,000                
Class B Ordinary Shares [Member]                    
Related Party Transactions (Details) [Line Items]                    
Offering and formation costs   $ 25,000                
Founder shares (in Shares)   5,750,000